FDA Inspection
SGS North America Inc.SGS North America Inc. – FDA Inspection, Mar 20, 2026
Record Details
This FDA Inspection record concerns SGS North America Inc., with an inspection on March 20, 2026, issued by the Chicago District Office, covering human drugs.
View Company Profile
ID · 8d90b2b7-d7cd-44af-83c0-2f2c8c5e0215
Inspection Facts
- Inspection number
- 1308948
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of SGS North America Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2025 | Not classified | Chicago District Office | |
| January 10, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 24, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 14, 2017 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| November 21, 2014 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for SGS North America Inc.
- FDA Inspection 1297328 - 2025-09-18
- FDA Inspection 1194448 - 2023-01-10
- FDA Inspection 1091237 - 2019-04-24
- FDA Inspection 1001725 - 2017-02-14
- FDA Inspection 904043 - 2014-11-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.